Distinguished senior scientist Mina Bissell is one of five recipients of the 2020 Canada Gairdner International Award – an annual honor given to scientists who have contributed to transformative human health research.
Many of the chemicals used to deter or eliminate disease-carrying mosquitoes can pollute ecosystems and drive the evolution of even more problematic, insecticide-resistant species – but thankfully, we may have better options soon.
A new material design has put the long-sought idea of artificial photosynthesis within reach.
A team of scientists used infrared and X-ray imaging performed at Berkeley Lab’s Advanced Light Source to determine the chemical mechanisms that allow soft tissue structures to persist in dinosaur bones – countering the long-standing scientific dogma that protein-based body parts can’t survive more than 1 million years.
In one week, Berkeley Lab is hosting the InnovationXLab Biomanufacturing Summit: An exclusive event aimed at bridging the gap between research and commercialization and paving the way toward a stronger bioeconomy.
Biomanufacturing – harnessing biological processes in cells and microbes to design and manufacture products – is revolutionizing how we make everything from futuristic consumer goods to sustainable fuels to breakthrough medicines. Every biomanufactured product can be traced back to discoveries in the lab, but translating that science into a real-world product can be tricky. Berkeley Lab is helping to move great ideas, like outdoor gear made from algae oil, from conception to commercialization.
An investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preliminary human studies and excellent results in animal studies. The drug, developed by Amgen and currently referred to as AMG 510, is the first therapy to reach clinical
Berkeley Lab’s Chris Mungall and Nomi Harris explain how agreeing on precise definitions of each rare disease can lead to more accurate diagnoses and better treatments, and share new evidence showing this endeavor is more important than ever.
A unique neural network tool is making it possible to accurately infer the interactions between the microbes that are present in a community and the metabolites they produce – a capability that will greatly advance research into the microbiomes in the environment and inside our bodies.
Berkeley Lab’s Rebecca Abergel, Roland Bürgmann, Cheryl A. Kerfeld, Michael Manga, Natalie Roe, and David V. Schaffer have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as a AAAS Fellow is an honor bestowed upon AAAS members by their peers.